Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna Isabel Neto Cancela"'
Autor:
Gilberto Schwartsmann, Sabrina A. Fernandes, Marc François Richter, Anna Isabel Neto Cancela, Luciane Pons Di Leone, Teresa Dalla Costa, André Borba Reiriz
Publikováno v:
Melanoma Research. 14:527-531
Thalidomide has anti-angiogenic and immunomodulatory activity, exhibiting antitumour effects in patients with multiple myeloma and, more rarely, in several other solid tumours. We evaluated the single-agent antitumour activity and toxicity profile of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21acde605d843e4a718d6896c0b2cf46
https://doi.org/10.1097/00008390-200412000-00014
https://doi.org/10.1097/00008390-200412000-00014
Autor:
Sabrina A. Fernandes, Marc François Richter, Ana C. Rodrigues, Gilberto Schwartsmann, Lissandra Dal Lago, Anna Isabel Neto Cancela, Luciane Pons Di Leone, Keylla T. Jung, Teresa Dalla Costa
Publikováno v:
Investigational New Drugs. 21:359-366
Introduction. This study was designed to estimate the percentage of objective tumor responses, toxicity profile, and obtain additional information about the plasma pharmacokinetics of thalidomide in patients with refractory and progressing metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8288f0ef60b98c7851a8f2515163f026
https://doi.org/10.1023/a:1025485031112
https://doi.org/10.1023/a:1025485031112
Autor:
E. Sander, Ana Paula Ferrary Caldas, Anna Isabel Neto Cancela, Holger J. Schünemann, A. F. Ferreira Filho, D. R. A. Mans, L. Di Leone, O. Campos Junior, T. Dalla Costa, Gilberto Schwartsmann
Publikováno v:
Scopus-Elsevier
Objective: The objective of this phase I study of oral etoposide in patients with refractory solid tumours was to determine the tolerability and pharmacokinetic profile and to establish the maximum tolerated dose (MTD) of the drug for this indication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ca8c97093840e7d102194d8977e819
https://doi.org/10.2165/00044011-200019050-00008
https://doi.org/10.2165/00044011-200019050-00008
Autor:
Anna Isabel Neto Cancela, Gilberto Schwartsmann, Luciane Pons DiLeone, Teresa Dalla Costa, Denis R. Mans, Ana Paula Ferrary Caldas, Eduardo Sprinz
Publikováno v:
American journal of clinical oncology. 24(2)
The purpose of this study was to examine the antitumor activity, toxic effects, and plasma pharmacokinetics of fractionated doses of oral etoposide aiming at the achievement of prolonged safe and active plasma drug levels in patients with AIDS-relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9120e3916594433f09fec137df86f172
https://pubmed.ncbi.nlm.nih.gov/11319295
https://pubmed.ncbi.nlm.nih.gov/11319295